COMPARISON OF CONVERTING-ENZYME-INHIBITOR AND CALCIUM-CHANNEL BLOCKER IN HYPERTENSIVE GLOMERULAR INJURY

被引:84
作者
TOLINS, JP [1 ]
RAIJ, L [1 ]
机构
[1] UNIV MINNESOTA,SCH MED,DEPT MED,MINNEAPOLIS,MN 55455
关键词
angiotensin converting enzyme inhibitors; calcium channel blockers; glomerular function; glomerulosclerosis; proteinuria; renal hypertension;
D O I
10.1161/01.HYP.16.4.452
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
The protective effect of converting enzyme inhibitors in experimental hypertensive glomerular injury is associated with decreased systemic arterial and glomerular capillary pressue. Although calcium channel blockers effectively lower systemic blood pressure, their effect on glomerular capillary pressure and on hypertensive glomerular injury is uncertain. We compared equihypotensive treatment with the calcium antagonist TA 3090 or the converting enzyme inhibitor captopril in post-salt hypertensive Dahl salt-sensitive (DS) rats for up to 5 weeks after five sixths nephrectomy. Before the nephrectomy, all rats demonstrated hypertension (mean 177 mm Hg), proteinuria (mean 175 mg/day), and mild glomerulosclerosis (mean injury score 35). Rats treated with captopril or TA 3090 demonstrated a significant and equivalent decrease in systolic blood pressure compared with untreated rats at 2, 3, and 5 weeks after five sixths nephrectomy; however, only captopril reduced proteinuria. Final proteinuria was actually increased in rats treated with TA 3090 cmpared with untreated rats. Glomerular injury score was significantly decreased in captopril-treated compared with untreated rats at 2 weeks (33 ± 9 versus 117 ± 10, p < 0.05) and 5 weeks (46 ± 9 versus 94 ± 24, p < 0.05), whereas treatment with TA 3090 delayed but did not prevenent progressive glomerular injury (2-week score 35 ± 7, p < 0.05 versus untreated; 5-week score 109 ± 19, p = NS versus untreated). Thus, in hypertensive DS rats after subtotal nephrectomy, treatment with a converting enzyme inhibitor reduced systemic blood pressure, proteinuria, and glomerulosclerosis. However, equihypotensive treatment with a calcium channel blocker did not reduce proteinura and delayed but did not prevent glomerulosclerosis. Thus, in the rat similar reductions in systemic blood pressure with these two classes of agents have disparate effects on the progression of chronic renal failure.
引用
收藏
页码:452 / 461
页数:10
相关论文
共 45 条
[1]  
ANDERSON S, 1988, KIDNEY INT, V33, P370
[2]   THERAPEUTIC ADVANTAGE OF CONVERTING ENZYME-INHIBITORS IN ARRESTING PROGRESSIVE RENAL-DISEASE ASSOCIATED WITH SYSTEMIC HYPERTENSION IN THE RAT [J].
ANDERSON, S ;
RENNKE, HG ;
BRENNER, BM .
JOURNAL OF CLINICAL INVESTIGATION, 1986, 77 (06) :1993-2000
[3]   SHORT AND LONG-TERM EFFECTS OF ANTIHYPERTENSIVE THERAPY IN THE DIABETIC RAT [J].
ANDERSON, S ;
RENNKE, HG ;
GARCIA, DL ;
BRENNER, BM .
KIDNEY INTERNATIONAL, 1989, 36 (04) :526-536
[4]   CONTROL OF GLOMERULAR HYPERTENSION LIMITS GLOMERULAR INJURY IN RATS WITH REDUCED RENAL MASS [J].
ANDERSON, S ;
MEYER, TW ;
RENNKE, HG ;
BRENNER, BM .
JOURNAL OF CLINICAL INVESTIGATION, 1985, 76 (02) :612-619
[5]  
AZAR S, 1978, J LAB CLIN MED, V91, P156
[6]  
AZAR S, 1979, JPN HEART J, V20, P138
[7]  
BERGSTROM J, 1986, CLIN NEPHROL, V25, P1
[8]  
BIDANI AK, 1987, AM J PHYSIOL, V252, pF1103
[9]  
BRENNER TM, 1982, NEW ENGL J MED, V307, P632
[10]   LONG-TERM ENALAPRIL AND VERAPAMIL IN RATS WITH REDUCED RENAL MASS [J].
BRUNNER, FP ;
THIEL, G ;
HERMLE, M ;
BOCK, HA ;
MIHATSCH, MJ .
KIDNEY INTERNATIONAL, 1989, 36 (06) :969-977